15 hours ago · Each patient evaluated by NarxCare gets a “Narx Report” that includes their NarxScores, Overdose Risk Score, Rx Graph, PDMP Data and my favorite, the Red Flags. The scores are based on the past two years of a patient’s prescription history, as well as their medical claims, electronic health records and even their criminal history. >> Go To The Portal
Each patient evaluated by NarxCare gets a “Narx Report” that includes their NarxScores, Overdose Risk Score, Rx Graph, PDMP Data and my favorite, the Red Flags. The scores are based on the past two years of a patient’s prescription history, as well as their medical claims, electronic health records and even their criminal history.
Full Answer
There’s a good chance your prescriptions are already being tracked by NarxCare and you don’t even know it. But NarxCare doesn’t just analyze opioid prescriptions. It also tracks other controlled substances, such as antidepressants, sedatives and stimulants.
Illicit drug use has, is, and will continue to be the main cause of the addiction and overdose crisis. Even the name NarxCare has a negative connotation. “Narx” stands for narcotics. And in today's environment, narcotics is a very negative word.
The scores are based on the past two years of a patient’s prescription history, as well as their medical claims, electronic health records and even their criminal history. Ohio, Michigan, Indiana, Iowa, and several other states are using NarxCare to supplement their own PDMPs.
It also enables delivery of NarxCare within Electronic Health Records (EHR) and Pharmacy Management Systems for those prescribers and dispensers in Texas who choose to access NarxCare through integration within their healthcare IT system via Appriss Health’s PMP Gateway solution.
A NarxCare Report is intended to raise healthcare provider and pharmacist awareness of the use of controlled substances by a patient as represented in the PDMP report.
NARxCHECK is a patented algorithm that analyzes controlled substance data from PDMPs and provides easy-to-use insights into a patient's controlled substance use. NARxCHECK quantifies risk with a 3-digit score, termed a “Narx Score,” which ranges from 000-999.
A Narx Score is calculated as a weighted average of the scaled values. A 50% weighting is applied to the milligram equivalencies with the remaining risk factors making up the other 50%. This type of weighting results in several reliable relationships.
NarxCare is a comprehensive platform to identify, prevent and manage substance use disorder (SUD). It empowers prescribers and dispensers to identify patients that may be at risk for addiction, overdose and death, and equips clinicians and care teams with the tools and technology they need to help those patients.
Narcissistic personality disorder — one of several types of personality disorders — is a mental condition in which people have an inflated sense of their own importance, a deep need for excessive attention and admiration, troubled relationships, and a lack of empathy for others.
A covert narcissist is someone who craves admiration and importance as well as lacks empathy toward others but can act in a different way than an overt narcissist.
Narx Scores are designed to draw awareness to the presence of significant PMP data. They represent information at a glance and are best used when incorporated into clinical work-flow as an automated result (i.e. the system automatically queries for an updated score as soon as the patient arrives).
It also enables delivery of NarxCare within Electronic Health Records (EHR) and Pharmacy Management Systems for those prescribers and dispensers in Texas who choose to access NarxCare through integration within their healthcare IT system via Bamboo Health's PMP Gateway solution.
Prescription Drug Monitoring Program - APPRISS.
The complete list of connected states includes: Alaska, Arizona, Arkansas, Colorado, Connecticut, Delaware, Georgia, Idaho, Illinois, Indiana, Iowa, Kansas, Kentucky, Louisiana, Maryland, Massachusetts, Michigan, Minnesota, Mississippi, Nevada, New Jersey, New Hampshire, New Mexico, New York, North Dakota, Ohio, ...
The overdose risk score (ORS) was calculated using a quantifiable reflection of prescription drug monitoring program data regarding patient-specific prescription drug use (sedatives, stimulants, and opioids combined) that is currently integrated into individuals' electronic medical records across 43 states in the US ...
The NarxCare Resources module provides Medication Assisted Treatment (MAT) locators, patient information handouts, and more. All features are accessible with a single click and automatically contextualized to an individual patient’s demographics.
Pharmacists and clinicians use NarxCare scores as indicators to further review details in the patient’s prescription history as they attend to the patient. NarxCare scores and reports are intended to aid, not replace, medical decision-making. None of the information presented should be used as sole justification for providing or refusing to provide medications.
NarxCare is delivered to your electronic health record (EHR) or pharmacy management system (PMS) using PMP Gateway. That means authorized prescribers and dispensers can access PDMP data and NarxCare analytics within their daily workflow for better awareness while making clinical decisions. There’s no need for an extra log-in or to re-enter patient data, and it is accessible via computer, tablet, or smartphone. NarxCare facilitates continuity of care for your patients.
NarxCare analyzes PDMP data and provides interactive visualization of usage patterns to help you identify potential risk factors and intervene with appropriate action.
Analytics and clinical resources to help identify, prevent, and manage substance use disorder
Increasing access to treatment, improving patient education and engagement, and enabling the coordination of care across the healthcare continuum through care team communications are key NarxCare features that are widely recognized as critical to success.
NarxCare also delivers care team communications, including the transmission of documents, enabling easy communication among all authenticated users. Messaging enables collaboration of care, alert and information sharing, and other functions important to clinical decision-making and patient care.
Each patient evaluated by NarxCare gets a “Narx Report” that includes their NarxScores, Overdose Risk Score, Rx Graph, PDMP Data and my favorite, the Red Flags. The scores are based on the past two years of a patient’s prescription history, as well as their medical claims, electronic health records and even their criminal history.
What is NarxCare? Appriss Health developed NarxCare as a “robust analytics tool” to help “care teams” (doctors, pharmacists, etc.) identify patients with substance use disorders. Each patient is evaluated and given a “risk score” based on their prescription drug history. According to Appriss, a patient is much more willing to discuss their substance abuse issues once they are red flagged as a possible abuser.
In 2019, Medicare will adopt policies making it even harder for patients to get high doses of opioid medication. Some insurers are already doing it. We’re already being policed enough as it is.
Unfortunately, the NarxCare scores do not reflect any of that. How can raw data on prescription medications be an indicator of abuse? I believe there is some merit in tracking and weeding out the rare abuser, but NarxCare doesn’t factor in all the “what if’s” that can happen to law-abiding and responsible patients.
But NarxCare doesn’t just analyze opioid prescriptions. It also tracks other controlled substances, such as antidepressants, sedatives and stimulants. If a patient is on any combination of those drugs, their risk scores and their chances of being red flagged will be higher – even if they’ve been safely taking the medications for years.
Even the name NarxCare has a negative connotation. “Narx” stands for narcotics. And in today’s environment, narcotics is a very negative word. NarxCare makes me feel like a narcotics police officer is just around the corner.
Sounds great doesn’t it? Except prescription drugs are not the problem and never really have been. Illicit drug use has, is, and will continue to be the main cause of the addiction and overdose crisis.
NarxCare Interpretation This 15-minute video provides users with the tools needed to interpret the NarxCare report and strategies for utilizing the report when making decisions regarding patient care.
NarxCare Demo This 7-minute video provides a brief, high-level overview of the NarxCare platorm, including directions for navigating the platform, understanding the NarxCare report, and locating the resource section.
Ensure the following domains are whitelisted within your organization.
For users accessing patient prescription history through a PMP Gateway integration:
If your software vendor or internal team who manages your system is unable to add add this element, due to the level of error to make the change, please contact the PMP help desk for further assistance.
Concerning Narx Scores are intended to trigger a discussion, not a decision. If a Narx Score raises concern, the recommended course of action is for the practitioner to evaluate the PDMP data and discuss any concerns with the patient. There is no Narx Score that is “normal”.
NARxCHECK quantifies risk with a 3-digit score, termed a “Narx Score”, which ranges from 000-999. Variables used to get this number include
The Narx Score is calculated as a weighted average of the scaled values. 50% of the weighting is applied to the milligram equivalencies of prescribed drugs and the remaining risk factors make up the other 50%.
Patients who use small amounts of medication with limited provider and pharmacy usage will have low scores.
However, a prescription for a narcotic does add to the sedative score , and vice versa. The distribution of the scores are such that in any given population, 75% will fall below 200, 5% will be above 500, and only 1% will be above 650.
There is no Narx Score that is “normal”. It must be applied to the clinical scenario before evaluating appropriateness. However, for protection of the practitioner, this discussion and decision MUST be documented in the patient record.